Cite

    Benjamin Burggraaf et al.. “A placebo‐controlled proof‐of‐concept study of alirocumab on postprandial lipids and vascular elasticity in insulin‐treated patients with type 2 diabetes mellitus.” Diabetes, obesity & metabolism, vol. 22, no. 5, 2020, pp. 807–816. http://access.bl.uk/ark:/81055/vdc_100103108632.0x000019